Loading...
XNYS
BLCO
Market cap5.95bUSD
Dec 04, Last price  
16.81USD
1D
-0.88%
1Q
11.99%
IPO
-6.61%
Name

Bausch + Lomb Corp

Chart & Performance

D1W1MN
XNYS:BLCO chart
P/E
P/S
1.25
EPS
Div Yield, %
Shrs. gr., 5y
0.10%
Rev. gr., 5y
4.79%
Revenues
4.77b
+15.15%
3,665,000,0003,778,000,0003,412,000,0003,765,000,0003,768,000,0004,146,000,0004,774,000,000
Net income
-317m
L+21.92%
710,000,000298,000,000-17,000,000182,000,00015,000,000-260,000,000-317,000,000
CFO
232m
P
763,000,000799,000,000522,000,000873,000,000345,000,000-17,000,000232,000,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Bausch + Lomb Corporation operates as an eye health company worldwide. It operates through three segments: Vision Care/Consumer Health Care, Ophthalmic Pharmaceuticals, and Surgical. The Vision Care/Consumer Health Care segment provides contact lens that covers the spectrum of wearing modalities, including daily disposable and frequently replaced contact lenses; and contact lens care products, over-the-counter eye drops, eye vitamins, and mineral supplements that address various conditions comprising eye allergies, conjunctivitis, and dry eye. The Ophthalmic Pharmaceuticals segment offers proprietary and generic pharmaceutical products for post-operative treatments, as well as for the treatment of eye conditions, such as glaucoma, ocular hypertension, and retinal diseases; and contact lenses for therapeutic use. The Surgical segment provides tools and technologies for the treatment of cataracts, and vitreous and retinal eye conditions; and intraocular lenses and delivery systems, phacoemulsification equipment, and other surgical instruments and devices. The company was founded in 1853 and is headquartered in Vaughan, Canada.
IPO date
May 06, 2022
Employees
13,000
Domiciled in
CA
Incorporated in
CA

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT